+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery



Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery



Journal of Neuro-Oncology 116(1): 187-193



The pupose of this study is to assess the long-term outcome and toxicity of fractionated stereotactic radiation therapy (FSRT) and stereotactic radiosurgery (SRS) for 100 vestibular schwannomas treated at a single institution. From 1993 to 2007, 104 patients underwent were treated with radiation therapy for vestibular schwannoma. Forty-eight patients received SRS, with a median prescription dose of 12.5 Gy for SRS (range 9.7-16 Gy). For FSRT, two different fraction schedules were employed: a conventional schedule (ConFSRT) of 1.8 Gy per fraction (Gy/F) for 25 or 28 fractions to a total dose of 45 or 50.4 Gy (n = 19); and a once weekly hypofractionated course (HypoFSRT) consisting of 4 Gy/F for 5 fractions to a total dose of 20 Gy (n = 37). Patients treated with FSRT had better baseline hearing, facial, and trigeminal nerve function, and were more likely to have a diagnosis of NF2. The 5-year progression free rate (PFR) was 97.0 after SRS, 90.5% after HypoFSRT, and 100.0% after ConFSRT (p = NS). Univariate analysis demonstrated that NF2 and larger tumor size (greater than the median) correlated with poorer local control, but prior surgical resection did not. Serviceable hearing was preserved in 60.0% of SRS patients, 63.2% of HypoFSRT patients, and 44.4% of ConFSRT patients (p = 0.6). Similarly, there were no significant differences in 5-year rates of trigeminal toxicity facial nerve toxicity, vestibular dysfunction, or tinnitus. Equivalent 5-year PFR and toxicity rates are shown for patients with vestibular schwanoma selected for SRS, HypoFSRT, and ConFSRT after multidisciplinary evaluation. Factors correlating with tumor progression included NF2 and larger tumor size.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055794235

Download citation: RISBibTeXText

PMID: 24142200

DOI: 10.1007/s11060-013-1282-4


Related references

Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: a single-institution experience. Frontiers in Oncology 3: 121, 2013

Fractionated stereotactic radiosurgery for vestibular schwannomas using cyberknife: A single institution experience. Jpma. Journal of the Pakistan Medical Association 66(9): 1089-1093, 2018

Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution. Journal of Radiation Research 55(2): 351-358, 2015

Single institution experience with 110 patient treated for acoustic schwannomas Analysis of Gamma Knife stereotactic radiosurgery and Linac fractionated stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 48(3 Suppl.): 254, 2000

Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases. Neurosurgery 69(6): 1200-1209, 2012

Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. International Journal of Radiation Oncology, Biology, Physics 80(5): 1485-1491, 2011

Stereotactic radiosurgery and fractionated stereotactic radiosurgery for vestibular schwannomas: A comparison of clinical outcomes from the RSSearch patient registry. Journal of Radiosurgery and Sbrt 6(1): 19-26, 2019

Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. International Journal of Radiation Oncology, Biology, Physics 85(2): 329-334, 2013

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: Comparative observations of 125 patients treated at one institution. International Journal of Radiation Oncology Biology Physics 50(5): 1265-1278, August 1, 2001

Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. International Journal of Radiation Oncology, Biology, Physics 100(2): 443-451, 2017

Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for management of vestibular schwannomas: initial experience with 17 cases. Acta Neurochirurgica. Suppl. 116: 37-44, 2013

Pseudoprogression of vestibular schwannomas after fractionated stereotactic radiation therapy. Journal of Radiation Oncology 2(1): 15-20, 2013

Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: A single-institution study. International Journal of Radiation Oncology Biology Physics 56(5): 1390-1396, August 1, 2003

Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. International Journal of Radiation Oncology, Biology, Physics 76(1): 193-200, 2010

Single fraction stereotactic radiation therapy (stereotactic radiosurgery) is a feasible method for treating intracranial meningiomas in dogs. Veterinary Radiology and Ultrasound 59(5): 632-638, 2018